Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Best Choice Biotech is a biotechnology company based in Guangzhou, China, specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. The company focuses on point-of-care testing (POCT) solutions, providing rapid diagnostic kits for a wide range of infectious diseases, including COVID-19, influenza, and respiratory syncytial virus (RSV). Their technology platform utilizes lateral flow immunoassays and fluorescence-based detection systems to deliver fast and accurate results for clinical and home use. Best Choice Biotech operates a large-scale manufacturing facility that is GMP and ISO 13485 certified, ensuring high-quality production standards. The company's products are distributed globally, supporting public health efforts in both developed and emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Best Choice.